期刊文献+

Controlled Drug Release Studies of Atenolol Using Differently Sulfonated Acryloxyacetophenone and Methyl Methacrylate Copolymer Resins as Drug Carriers 被引量:2

Controlled Drug Release Studies of Atenolol Using Differently Sulfonated Acryloxyacetophenone and Methyl Methacrylate Copolymer Resins as Drug Carriers
原文传递
导出
摘要 2-Acryloxyacetophenone (AAP) was prepared and subjected to suspension polymerization with methyl methacrylate (MMA) using azobisisobutyronitrile (AIBN) as free radical initiator. The differently sulfonated AAP-MMA cross-linked copolymer cationic exchange resins were prepared by sulfonation with concentrated sulphuric acid at 70 ~C. Several characteristics of the prepared resins were evaluated, i.e. FTIR, the ion-exchange capacity (IEC), thermo gravimetric analysis (TGA), particle size distribution and microscopic morphology. The resin characteristics were altered with degree of sulfonation, providing that differently sulfonated resins could be prepared. The behavior of atenolol (ATL) loading and in vitro release in the USP stimulated gastric and intestinal fluids of the obtained resins were evaluated. The drug loaded in the resin increased with increasing degree of sulfonation and hence the drug binding site in resin employed. The drug release was lower from the resins with higher content of sulfonic group due to the increase in the diffusive path depth. The drug release was a little lower in stimulated gastric fluid (SGF) than in stimulated intestinal fluids (SIF). The basic groups, ionized to a little greater extent in SGF and preferred binding with the resin rather than releasing. Hence, the differently sulfonated resins could be utilized as novel carriers for drug delivery. 2-Acryloxyacetophenone (AAP) was prepared and subjected to suspension polymerization with methyl methacrylate (MMA) using azobisisobutyronitrile (AIBN) as free radical initiator. The differently sulfonated AAP-MMA cross-linked copolymer cationic exchange resins were prepared by sulfonation with concentrated sulphuric acid at 70 ~C. Several characteristics of the prepared resins were evaluated, i.e. FTIR, the ion-exchange capacity (IEC), thermo gravimetric analysis (TGA), particle size distribution and microscopic morphology. The resin characteristics were altered with degree of sulfonation, providing that differently sulfonated resins could be prepared. The behavior of atenolol (ATL) loading and in vitro release in the USP stimulated gastric and intestinal fluids of the obtained resins were evaluated. The drug loaded in the resin increased with increasing degree of sulfonation and hence the drug binding site in resin employed. The drug release was lower from the resins with higher content of sulfonic group due to the increase in the diffusive path depth. The drug release was a little lower in stimulated gastric fluid (SGF) than in stimulated intestinal fluids (SIF). The basic groups, ionized to a little greater extent in SGF and preferred binding with the resin rather than releasing. Hence, the differently sulfonated resins could be utilized as novel carriers for drug delivery.
出处 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2014年第3期280-291,共12页 高分子科学(英文版)
基金 The University Grants Commission,New Delhi for its funding of this work Indian Institute of Science,Bangalore for its instrumental support Department of Physics,Sri Venkateswara University,Tirupathi,for its assistance in the SEM study UGC,New Delhi for its support under SAP DST,New Delhi for its support under FIST
关键词 2-Acryloxyacetophenone Methyl methacrylate Different sulfonation Cationic exchange resins ATENOLOL In vitro drug release. 2-Acryloxyacetophenone Methyl methacrylate Different sulfonation Cationic exchange resins Atenolol In vitro drug release.
  • 相关文献

参考文献36

  • 1Jain,N.K. Advanced Drug Delivery System[M].Aantares Pharma,N.J,USA,2005.290. 被引量:1
  • 2Borodkin;S;Sundberg;D.P.查看详情[J],Journal of Pharmaceutical Sciences19711523. 被引量:1
  • 3Sriwongjanya;M;Bodmeier;R.查看详情[J],International Journal of Pharmaceutics199729. 被引量:1
  • 4Cuna;M;Jato;J.L.V;Torres;D.查看详情[J],International Journal of Pharmaceutics2000151. 被引量:1
  • 5Ichikawa;H;Fujioka;K;Adeyeye;M.C;Fukumori;Y.查看详情[J],International Journal of Pharmaceutics200167. 被引量:1
  • 6Pongjanyakrul;T;Priprem;A;Chitropas;P;Puttipipatkhachorn;S.查看详情[J],AAPS PharmSciTech2005El90. 被引量:1
  • 7Borodkin,S. Ion exchange resins and sustained release[A].New York:Marcel Dekker,Inc,1993.203. 被引量:1
  • 8Notari,R.E. Biopharmaceutics and Clinical Pharmacokinetics[M].New York,Basel,Switzerland.Marcel Dekker Inc,1987.130. 被引量:1
  • 9Raghunathan;Y;Amsel;L;Hinsvark;O;Bryant;W.J.查看详情[J],Pharmaceutical Sciences1981379. 被引量:1
  • 10Ogger;K.E;Noory;C;Gabay;J;Shah;V.P.and Skelly;J.P.查看详情[J],Pharmaceutical Technology199184. 被引量:1

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部